92
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Bio-Fermentation Derived Hyaluronic Acid and Healthcare Costs Following Knee Arthroplasty

ORCID Icon, , ORCID Icon, ORCID Icon, &
Pages 575-585 | Received 09 Nov 2021, Accepted 13 Aug 2022, Published online: 30 Aug 2022

References

  • American Academy of Orthopaedic Surgeons. Treatment of Osteoarthritis of the Knee. Evidence-based Guideline; 2013. Available from: https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/osteoarthritis-of-the-knee-2nd-editiion-clinical-practice-guideline.pdf. Accessed October 19, 2020.
  • Rankin EA, Alarcon GS, Chang RW, Cooney LM. NIH consensus statement on total knee replacement. NIH Consens State Sci Statements. 2003;20(1):1–34.
  • American Academy of Orthopaedic Surgeons. Appropriate use criteria for non-arthroplasty treatment of osteoarthritis of the knee; 2013. Available from: https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/auc-non-arthroplasty-treatment-osteoarthritis-knee.pdf. Accessed October 19, 2020.
  • Bedard NA, Dowdle SB, Anthony CA, et al. The AAHKS clinical research award: what are the costs of knee osteoarthritis in the year prior to total knee arthroplasty? J Arthroplasty. 2017;32(9S):S8–S10e11. doi:10.1016/j.arth.2017.01.011
  • Cohen JR, Bradley AT, Lieberman JR. Preoperative interventions and charges before total knee arthroplasty. J Arthroplasty. 2016;31(12):2730–2735 e2737. doi:10.1016/j.arth.2016.05.048
  • Weick JW, Bawa HS, Dirschl DR. Hyaluronic acid injections for treatment of advanced osteoarthritis of the knee: utilization and cost in a national population sample. J Bone Joint Surg Am. 2016;98(17):1429–1435. doi:10.2106/JBJS.15.01358
  • Malanga G, Niazi F, Kidd VD, et al. Knee osteoarthritis treatment costs in the medicare patient population. Am Health Drug Benefits. 2020;13(4):144–153.
  • Concoff A, Niazi F, Farrokhyar F, Alyass A, Rosen J, Nicholls M. Delay to TKA and costs associated with knee osteoarthritis care using intra-articular hyaluronic acid: analysis of an administrative database. Clin Med Insights Arthritis Musculoskelet Disord. 2021;14:1179544121994092. doi:10.1177/1179544121994092
  • Altman RD, Rosen JE, Bloch DA, Hatoum HT, Korner P. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum. 2009;39(1):1–9. doi:10.1016/j.semarthrit.2009.04.001
  • Waddell DD, Bricker DC. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg. 2006;19(1):19–27. doi:10.1055/s-0030-1248072
  • Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E. Product differences in intra-articular hyaluronic acids for osteoarthritis of the knee. Am J Sports Med. 2016;44(8):2158–2165. doi:10.1177/0363546515609599
  • Hummer CD, Angst F, Ngai W, et al. High molecular weight Intraarticular hyaluronic acid for the treatment of knee osteoarthritis: a network meta-analysis. BMC Musculoskelet Disord. 2020;21(1):702. doi:10.1186/s12891-020-03729-w
  • Vannabouathong C, Bhandari M, Bedi A, et al. Nonoperative treatments for knee osteoarthritis: an evaluation of treatment characteristics and the intra-articular placebo effect: a systematic Review. JBJS Rev. 2018;6(7):e5. doi:10.2106/JBJS.RVW.17.00167
  • Phillips M, Vannabouathong C, Devji T, et al. Differentiating factors of intra-articular injectables have a meaningful impact on knee osteoarthritis outcomes: a network meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2020;28(9):3031–3039. doi:10.1007/s00167-019-05763-1
  • Altman RD, Manjoo A, Fierlinger A, Niazi F, Nicholls M. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321. doi:10.1186/s12891-015-0775-z
  • Ong KL, Runa M, Xiao Z, Ngai W, Lau E, Altman RD. Severe acute localized reactions following intra-articular hyaluronic acid injections in knee osteoarthritis. Cartilage. 2020;13:1474S–86S.
  • Ong KL, Anderson AF, Niazi F, Fierlinger AL, Kurtz SM, Altman RD. Hyaluronic acid injections in medicare knee osteoarthritis patients are associated with longer time to knee arthroplasty. J Arthroplasty. 2016;31(8):1667–1673. doi:10.1016/j.arth.2016.01.038
  • Bedard NA, Pugely AJ, Elkins JM, et al. The John N. Insall Award: do intraarticular injections increase the risk of infection after TKA? Clin Orthop Relat Res. 2017;475(1):45–52. doi:10.1007/s11999-016-4757-8
  • Cancienne JM, Werner BC, Luetkemeyer LM, Browne JA. Does timing of previous intra-articular steroid injection affect the post-operative rate of infection in total knee arthroplasty? J Arthroplasty. 2015;30(11):1879–1882. doi:10.1016/j.arth.2015.05.027
  • Richardson SS, Schairer WW, Sculco TP, Sculco PK. Comparison of infection risk with corticosteroid or hyaluronic acid injection prior to total knee arthroplasty. J Bone Joint Surg Am. 2019;101(2):112–118. doi:10.2106/JBJS.18.00454
  • Kurtz SM, Mont M, Chen AF, et al. Intra-articular corticosteroid or hyaluronic acid injections are not associated with periprosthetic joint infection risk following total knee arthroplasty. J Knee Surg. 2021:35;983–996
  • Gu A, Malahias MA, Cohen JS, et al. Prior knee arthroscopy is associated with increased risk of revision after total knee arthroplasty. J Arthroplasty. 2020;35(1):100–104. doi:10.1016/j.arth.2019.08.043
  • Kamath AF, Ong KL, Lau E, et al. Quantifying the burden of revision total joint arthroplasty for periprosthetic infection. J Arthroplasty. 2015;30(9):1492–1497. doi:10.1016/j.arth.2015.03.035
  • Altman R, Lim S, Steen RG, Dasa V. Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: evidence from a Large U.S. health claims database. PLoS One. 2015;10(12):e0145776. doi:10.1371/journal.pone.0145776
  • Dasa V, Lim S, Heeckt P. Real-world evidence for safety and effectiveness of repeated courses of hyaluronic acid injections on the time to knee replacement surgery. Am J Orthop. 2018;47:7.
  • Chitnis AS, Etter K, Holy CE, et al. Real-world impact of the high concentration non-avian high molecular weight hyaluronan on pain medication use among osteoarthritis patients. Curr Med Res Opin. 2019;35(9):1523–1527. doi:10.1080/03007995.2019.1596670
  • McIntyre LF, Beach W, Bhattacharyya S, Yadalam S, Bisson B, Kim M. Impact of hyaluronic acid injections on utilization of pain management medications. Am J Pharm Benefits. 2017;9(6):195–199.
  • Altman RD, Rosen JE, Bloch DA, Hatoum HT. Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial. Osteoarthritis Cartilage. 2011;19(10):1169–1175. doi:10.1016/j.joca.2011.07.001
  • Wilson LA, Liu J, Fiasconaro M, Poeran J, Nwachukwu BU, Memtsoudis SG. Increased use of intra-articular steroid injection to treat osteoarthritis is associated with chronic opioid dependence after later total knee arthroplasty but not total hip arthroplasty. J Arthroplasty. 2020;35(8):1979–1982. doi:10.1016/j.arth.2020.04.012
  • Niazi F, Ong KL, Kidd VD, et al. Decrease in opioid and intra-articular corticosteroid burden after intra-articular hyaluronic acid for knee osteoarthritis treatment. Pain Manag. 2020;10:387–397. doi:10.2217/pmt-2020-0057